CD274 and cancer: All of these enrichment analyses suggest broad ETV7 involvement in immune-related processes and pathways, including the following: T cell activation; Th1, Th2, and Th17 cell differentiation; PD-L1 expression and PD-1 checkpoint pathway in cancer; and antigen processing and presentation (Figures 5–7).